JMPWA
BSTC

JP Morgan Private Wealth Advisors’s BioSpecifics Technologies Corp. BSTC Stock Holding History

JP Morgan Private Wealth Advisors’s Portfolio BSTC Stock Details BSTC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q3 		– Sell
-3,770
Closed -$231K – 1646
2020
Q2 		$231K Buy
3,770
+68
+2% +$3.93K ﹤0.01% 1412
2020
Q1 		$209K Sell
3,702
-89
-2% -$5.07K ﹤0.01% 1285
2019
Q4 		$216K Sell
3,791
-238
-6% -$12.6K ﹤0.01% 1368
2019
Q3 		$216K Buy
+4,029
New +$235K ﹤0.01% 1318

Other funds holding BSTC

Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
RHJA
Rice Hall James & Associates San Diego, California $1.8B AUM 36.16% 1-Year Est. Return
Russell Investments Group
Russell Investments Group London, United Kingdom $93.1B AUM 28.26% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
RA
Royce & Associates New York $10.1B AUM 42.88% 1-Year Est. Return

JP Morgan Private Wealth Advisors's BSTC Position: Q3 2020 in Review

JP Morgan Private Wealth Advisors sold out of BioSpecifics Technologies Corp. (BSTC) in Q3 2020, closing a stake of 3,770 shares — an estimated $231K sold.

JP Morgan Private Wealth Advisors first reported a position in BSTC in Q3 2019 and held it in 4 quarters. The position peaked at $231K in Q2 2020. 113 funds tracked by Wall St. Rank hold BSTC as of Q3 2020.

  • JP Morgan Private Wealth Advisors reported no remaining BioSpecifics Technologies Corp. position as of Q3 2020 after selling out during the quarter.
  • JP Morgan Private Wealth Advisors sold 3,770 BioSpecifics Technologies Corp. shares in Q3 2020, an estimated $231K.
  • JP Morgan Private Wealth Advisors first reported a position in BioSpecifics Technologies Corp. in Q3 2019 and held it in 4 quarters.
  • JP Morgan Private Wealth Advisors's BioSpecifics Technologies Corp. position peaked at $231K in Q2 2020.
  • 113 funds tracked by Wall St. Rank held BioSpecifics Technologies Corp. as of Q3 2020.

Based on JP Morgan Private Wealth Advisors's 13F filing for Q3 2020, filed 12 Nov 2020.